Wealth Enhancement Advisory Services’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $48.2K | Buy |
30,113
+9,739
| +48% | +$15.6K | ﹤0.01% | 3204 |
|
|
2025
Q1 | $24K | Sell |
20,374
-2,599
| -11% | -$3.07K | ﹤0.01% | 2873 |
|
|
2024
Q4 | $42K | Sell |
22,973
-37,819
| -62% | -$69.2K | ﹤0.01% | 2841 |
|
|
2024
Q3 | $103K | Buy |
60,792
+15,519
| +34% | +$26.4K | ﹤0.01% | 2524 |
|
|
2024
Q2 | $62K | Buy |
45,273
+29,696
| +191% | +$40.7K | ﹤0.01% | 2428 |
|
|
2024
Q1 | $58.4K | Sell |
15,577
-897
| -5% | -$3.36K | ﹤0.01% | 2322 |
|
|
2023
Q4 | $162K | Buy |
16,474
+2,436
| +17% | +$23.9K | ﹤0.01% | 2117 |
|
|
2023
Q3 | $117K | Buy |
+14,038
| New | +$117K | ﹤0.01% | 2068 |
|